<DOC>
	<DOCNO>NCT00199966</DOCNO>
	<brief_summary>The purpose research compare safely well medicine work treat child teenager age 6 17 year diagnosis Bipolar Disorder .</brief_summary>
	<brief_title>Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder</brief_title>
	<detailed_description>There accept , well-studied treatment Pediatric Bipolar Disorder treatment often follow adult study . The primary objective study determine subject safely easily switch divalproex sodium Depakote ER determine Depakote ER safe effective pediatric patient Bipolar I II . Secondary objective include determine serum level valproic acid 20 hour administration Depakote ER steady rate determine co-administration stimulant effect serum level valproic acid . Thirty subject , age 6-17 year , diagnosis Bipolar I II currently asymptomatic , accord score le 10 Young Mania Rating Scale , desire change daily dose , desire change likelihood decrease side-effects , recruit clinic community . If subject complete baseline evaluation ( include diagnostic confirmation ) , lab , rating scale still eligible participate , subject switch one night twice-a-day divalproex sodium ( DVP ) divalproex sodium extend release ( DVP ER ) . The potential benefit research new information add field child adolescent psychiatry possibility medication change may result improve symptom mania side effect medication related peak trough level . The potential benefit study outweigh possible risk .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Diagnosis Bipolar I II confirm KSADS clinical interview . Ages 6 17 year 11 month . YMRS score &lt; 10 , consistent minimal symptom mania . Or desire change medication due simplify dose schedule reduce unwanted side effect divalproex sodium . Ability willingness subject parent ( ) /guardian ( ) provide inform write assent/consent . Diagnosis : Pervasive Developmental Disorders , Schizophrenia spectrum disorder , Obsessive Compulsive Disorder . Concurrent medical condition require medication unstable . Current suicidal thought . Recent suicidal behavior . Pregnancy sexually active female use reliable form contraception . Previous inadequate response DVP ER . Known hypersensitivity DVP DVP ER . Recent inpatient hospitalization suicidality homicidality , ( last 6 month ) . Subjects clinically stable suffer significant side effect current medical regimen . Use antidepressant within last 2 week , 4 week fluoxetine . Recent ( last 3 month ) substance abuse dependence . Urine drug screen obtain question arises .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Bipolar Disorder ; Pediatric Bipolar Disorder ; Depakote ER</keyword>
</DOC>